[
    [
        {
            "time": "2020-12-08",
            "original_text": "沃森生物暂停出售子公司股权背后：全力冲击新冠疫苗 建基地有资金压力 资产异常",
            "features": {
                "keywords": [
                    "沃森生物",
                    "子公司股权",
                    "新冠疫苗",
                    "资金压力",
                    "资产异常"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物暂停出售子公司股权背后：全力冲击新冠疫苗 建基地有资金压力 资产异常",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-08",
            "original_text": "沃森生物回复关注函：不存在年底突击出售资产调节利润情形 关注函",
            "features": {
                "keywords": [
                    "沃森生物",
                    "关注函",
                    "出售资产",
                    "利润调节"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物回复关注函：不存在年底突击出售资产调节利润情形 关注函",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-08",
            "original_text": "沃森生物回复关注函：没有“贱卖”、不存在关联关系或利益安排 关注函",
            "features": {
                "keywords": [
                    "沃森生物",
                    "贱卖",
                    "利益安排",
                    "关注函"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物回复关注函：没有“贱卖”、不存在关联关系或利益安排 关注函",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-08",
            "original_text": "沃森生物股价放量下挫20% 资产异常",
            "features": {
                "keywords": [
                    "沃森生物",
                    "股价下挫",
                    "资产异常"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物股价放量下挫20% 资产异常",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-08",
            "original_text": "沃森生物叫停股权转让，股价却跌跌不休，投资者何去何从？ 资产异常",
            "features": {
                "keywords": [
                    "沃森生物",
                    "股权转让",
                    "股价下跌",
                    "资产异常"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物叫停股权转让，股价却跌跌不休，投资者何去何从？ 资产异常",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]